Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
If Healight gets approval for emergency use (esp. globally) that's a huge market for upper respiratory pathogens; over 3 million deaths a year that could possibly be avoided.
Exceptional timing for a change. I just doubled my position when Link last dropped below $12. If there's another dip I'll get even more. No doubt this'll above $15 before YE. The Spark drop will cause a long line waiting to buy it.
18 institutions and wallets supporting Spark's airdrop:
"At the time of publication, (October 17, 2020), a total of 18 institutions and wallets support Spark’s airdrop. Among the exchanges are: Poloniex, Uphold, NDAX, bitrue, GateHub, AnchorU$D, btcmarkets, CoinSpot. Among the wallets: Ledger, Xumm, and Exodus are the most prominent. In response to rumors of an alleged withdrawal of support for Spark, Poloniex and Uphold have reconfirmed their support."
https://www.crypto-news-flash.com/ripple-binance-and-kraken-could-participate-in-spark-airdrop/
Drugdoctor, do you think AYTU would consider a temporary stock buyback, if that was needed to maintain the $1.00 price for NASDAQ?
Ripple News: 12 Things for XRP Investors to Know Today
"Cryptocurrency traders are likely keeping a close eye on Ripple news as the price of XRP climbs higher on Tuesday.
Here’s what investors need to know about the most recent Ripple news.
- Ripple is a networking company that allows users to transfer funds around the world.
- The company offers its own cryptocurrency, XRP, for users to make use of.
- XRP has been gaining strength over this last week and that growth is continuing today.
- The climb initially started on Nov. 2 after the company experienced a dip.
- Since then, the digital currency has seen massive gains increase it from 23 cents to 30 cents today.
- If this trend continues, it means that XRP may finally return to its high of 34 cents earlier this year.
- That high happened in February before the cryptocurrency, along with just about everything else, took a dive with the novel coronavirus pandemic getting into full swing.
- XPR was hit especially hard at that time and has been in recovering since hitting a low of 15 cents in March.
- It appears that the jump in XRP has to do with a similar increase for bitcoin.
- The cryptocurrency has been on the rise of late and just broke $17,000 earlier today.
=That’s worth noting as bitcoin hasn’t been worth that much since December 2017.
- It’s possible that both cryptocurrencies will continue to rise higher as markets are still recovering from the coronavirus.
XRP was up 1.5% as of Tuesday afternoon."
https://investorplace.com/2020/11/ripple-news-what-to-know-for-xrp-investors/
Ripple: XUMM banking app soon ready for mass adoption
o XRPL Labs has released the latest beta version for the banking app XUMM.
o XUMM is about to launch the productive version and release the app to the public.
https://www.crypto-news-flash.com/ripple-xumm-banking-app-soon-ready-for-mass-adaptation/
She's taken off again.
Now you did it. lol . After saying it couldn't break $13 you pissed it off.
ISS - EVA upgrades AYTU BIOSCIENCE ORD SHS from SELL to UNDERWEIGHT.
BY Investars Analyst Actions - public
— 2:10 AM ET 11/17/2020
On November 17, 2020 ISS - EVA upgraded AYTU BIOSCIENCE ORD SHS from SELL to UNDERWEIGHT.
Top Crypto Strategist Bullish on XRP As Number of Whales Invested in Crypto Asset Hits All-Time High
https://dailyhodl.com/2020/11/16/top-crypto-strategist-bullish-on-xrp-as-number-of-whales-invested-in-crypto-asset-hits-all-time-high/
Ripple files for yet another new trademark in the US
Ripple’s new filing with the USPTO is for the trademark “PayString.”
https://cointelegraph.com/news/ripple-files-for-yet-another-new-trademark-in-the-us
Potential of Healight
“Our team has shown that administering a specific spectrum of UV-A light can eradicate viruses in infected human cells (including coronavirus) and bacteria in the area while preserving healthy cells,” stated Dr. Pimentel of Cedars-Sinai. Ali Rezaie, MD, one of the inventors of this technology states, “Our lab at Cedars-Sinai has extensively studied the effects of this unique technology on bacteria and viruses. Based on our findings we believe this therapeutic approach has the potential to significantly impact the high morbidity and mortality of coronavirus-infected patients and patients infected with other respiratory pathogens. We are looking forward to partnering with Aytu BioScience to move this technology forward for the benefit of patients all over the world.”
https://www.sec.gov/Archives/edgar/data/1385818/000165495420004215/aytu_ex991.htm
.
Just a fraction of the potential for Healight beyond covid-19 is for respiratory pathogens.
"Globally more than 1.5 million deaths annually from respiratory infections are attributable to the environment, including at least 42% of lower respiratory infections and 24% of upper respiratory infections in developing countries." (Poster's note: 1.3 million have died from covid-19 to date).
https://www.google.com/search?q=how+many+people+per+year+die+from+respiratory+pathogens&oq=how+many+people+per+year+die+from+respiratory+pathogens&aqs=chrome..69i57.24091j0j15&sourceid=chrome&ie=UTF-8
No kidding the future looks good.
A 12-month increase in revenue of 766% year-over-year. How many even > $100/share companies do that?
Thanks for sharing Stonewall...good article.
From AYTU's Form 10-K:
"Our operations have historically consumed cash and are expected to continue to require cash, but at a declining rate. Revenues have increased 277% and 100% for each of the years ended June 30, 2020 and 2019, respectively, and are expected to continue to increase, allowing us to rely less on our existing cash balance and proceeds from financing transactions. Despite increased revenue, cash used in operations during the year ended June 30, 2020 was $28.4 million compared to $13.8 million for the year ended June 30, 2019. The increased cash use was due to funding existing operations as well as the funding required to consummate and integrate the operations of two significant transactions which substantially increased the size and scope of our commercial operations. Additional funds were required to license the Healight Platform and pursue its development.
Agree. If you look at where AYTU is headed and not where it's been (rearview mirror) is looks promising and profitable.
Healight Platform Technology
https://aytubio.com/healight/
(Good video on this link BTW).
Ripple buys back XRP for the first time to support 'healthy markets'
https://www.theblockcrypto.com/linked/83995/ripple-purchased-xrp-q3-2020
Why is attending this conference not a big deal? Just curious.
"...500 participating companies and 3,000 attendees. Our conference will again feature leading public and private companies from the pharmaceuticals, biotechnology, medical technology, and healthcare services sectors from the Americas, Europe, Middle East, Africa, Asia, and Australia..."
https://www.jefferies.com/IdeasAndPerspectives/Conferences/325/111720
Ripple buys back XRP for the first time to support 'healthy markets'
https://www.theblockcrypto.com/linked/83995/ripple-purchased-xrp-q3-2020
Don't forget the short term gains tax will reduce your trade profits.
Ripple Opens Dubai HQ as Blockchain Firm Mulls Le
https://www.coindesk.com/ripple-opens-dubai-hq-as-blockchain-firm-mulls-leaving-us
Other article on subject:
Ripple opens regional office in Dubai following volatile Q3 for XRP
https://cointelegraph.com/news/ripple-announces-dubai-offices-following-volatile-q3-for-xrp
I think we may have a short squeeze coming before Thursday. Just sayin'.
AYTU Bioscience Short Positions
https://fintel.io/ss/us/aytu
"...the Company will present its operational results for the fiscal first quarter ended September 30, 2020 on November 12, 2020, at 4:30 p.m. ET..."
After close next Thursday. Sounds like we may have a buying spree Friday (if my expectations are correct).
GLTA
I don't know what it is, but here's INNV's website. If it's important it should be noted there.
https://innovuspharma.com/
I could say the same thing about bitcoin.
Chainlink has outperformed BTC in 2019.
ROI:
Bitcoin..... Change vs USD (2019) +84.31
Chainlink... Change vs USD (2019) +485.16%
Think how much money you'd make if you invested $15,000+ in Chainlink in 2019.
https://messari.io/asset/bitcoin/metrics
https://messari.io/asset/chainlink/metrics
I'm in XRP for future utility and Chainlink for ROI.
Ripple: FXCoin and SBI testing XRP based solution against remittance volatility
o FXCoin with Ripple’s partner, SBI, and others will launch a product based on XRP to reduce volatility when sending remittances.
o The XRP based solution will enter a pilot phase at the end of November. If successful it will be adopted by FXCoin partners.
https://www.crypto-news-flash.com/ripple-fxcoin-and-sbi-testing-xrp-based-solution-against-remittance-volatility/
Ripple: New XRP Ledger upgrade is Gamechanger according to David Schwartz
o According to Ripple CTO David Schwartz, the new XRPL upgrade is a gamechanger that further expands the decentralization of the network.
o For now the upgrade is only available in the test network Rippled 1.6.0 and is still being checked for bugs.
https://www.crypto-news-flash.com/ripple-new-xrp-ledger-upgrade-is-gamechanger-according-to-david-schwartz/
This stock has been dead for years. The CEO took off for Canada back then.
It may be my unbridled optimism, but when I compare AYTU to other pharmaceuticals it doesn't look as negative as some see it.
AYTU's revenue growth was 84 times better than the industry average.
The (diluted additional shares incl.) EPS Growth was at east twice as much as the ind. avg.
Profit margins aren't that far out of whack with the industry's.
Some deep smart pockets hold a lot of AYTU. There's got to be a good reason for that.
Just sayin'.
JavaScript Smart Contract Platform Agoric Integrates with Chainlink Oracle
https://www.infoq.com/news/2020/10/javascript-smart-contract-agoric/
I fail to see how their progressive qtrs reported losses of $ 1.95 to .72 to .50 to .32 to .15 to .02, in that order, reflect more cash burn and more losses. Mathematically it appears to be less cash burn and less losses. Perhaps even profits next qtr. or certainly by the qtr after that if this trend continues.
IMO AYTU will be profitable soon. If you look at their history (before the pandemic) their quarterly losses were starting to shrink. With the following actions, revenues should certainly increase dramatically. I'm guessing profits will too because not all costs are variable.
Post pandemic:
Aytu BioScience, Inc. ( AYTU ) reported earlier last month that it had signed an agreement to distribute the Pinnacle CovID RAD Rapid Antigen Detection Test worldwide. The rapid antigen test, which delivers results in fifteen minutes, tests for the presence of the SARS-CoV-2 virus antigen via a nasopharyngeal sample and can be conducted without the use of laboratory equipment. Pinnacle IVD Corporation plans to scale U.S. manufacturing capacity for the CovID RAD Rapid Antigen Detection Test to 25 million tests per month. The CovID RAD Rapid Antigen Detection Test was developed by U.S.-based Pinnacle IVD Corporation, a leader in colon cancer screening and other in-vitro diagnostics. The Pinnacle CovID RAD Rapid Antigen Detection Test is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein antigens from SARS-CoV-2 in nasopharyngeal swab specimens from individuals who are suspected of COVID-19 by their healthcare provider.
-AND-
In response to the pandemic, new disinfecting technology has appeared, utilizing UV light or, on a larger scale, automatic vehicle disinfections. The latter was invented by the passenger transport manufacturing firm Irizar, which has developed the technology to address the issue of infection control on buses, including a smart 'access control' camera system placed at the front of the bus. Optec International, Inc. (OTC: OPTI), Halberd Corp. ( HALB ) , Citius Pharmaceuticals Inc. ( CTXR ) , CytoDyn Inc. (OTC: CYDY), Aytu BioScience, Inc. ( AYTU ).
Ripple: This is why XRPL is superior to other public blockchains
o Ripple’s CTO points out the advantages of the XRP Ledger consensus algorithm compared to Bitcoin and Ethereum.
o “Negative UNL” proposal could be introduced with the launch of XRPL2
https://www.crypto-news-flash.com/ripple-this-is-why-xrpl-is-superior-to-other-public-blockchains/